## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and conclusions as presented in the abstract; no access to full text, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors report the NMR solution structure of AcrIE5, a novel αβ fold with three α-helices and two β-strands, a conserved mobile loop between β-strands, and AlphaFold-based prediction of its binding to the type I-E Cascade complex at a cleft formed by Cas8e, Cas7e, and Cas5e. They propose that AcrIE5 competes with DNA for the PAM recognition site, analogous to AcrIE3 and AcrIE4, and that the mobile loop contributes to host-specific anti-CRISPR activity.
- **Visible evidence base** Abstract text only; no structural coordinates, NMR restraints, AlphaFold confidence metrics, binding data, or experimental validation are provided
- **Missing materials affecting confidence** Full manuscript, all figures and tables, NMR data quality metrics, AlphaFold prediction details, binding assay results, sequence alignment data, and any functional validation experiments

## Reviewer
- **Overall assessment** The abstract presents a potentially interesting structural characterization of an anti-CRISPR protein, with a plausible mechanistic hypothesis. However, the evidence base available for review is limited to the abstract, and several key claims cannot be evaluated without access to the underlying data. The novelty of the fold and the functional significance of the mobile loop are intriguing but require careful validation. The claim that AcrIE5 competes with DNA binding is presented as a suggestion, which is appropriately cautious, but the supporting evidence is not visible.
- **Who would be interested in the results, and why** Researchers in the fields of CRISPR biology, host-pathogen interactions, structural biology, and protein NMR spectroscopy would be interested. The work contributes to the growing understanding of anti-CRISPR mechanisms and may inform efforts to engineer or inhibit CRISPR-Cas systems for biotechnological applications.
- **Major strengths** The study addresses a relevant and timely topic in anti-CRISPR biology. The use of NMR to determine a novel fold adds structural diversity to the anti-CRISPR protein family. The integration of experimental structure determination with AlphaFold predictions is a modern and potentially powerful approach. The identification of a conserved mobile loop with host-specific variation is a notable observation that could have functional implications.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
- **Technical failings that need to be addressed before the case is established** R1-M1 (structural data quality and validation), R1-M2 (AlphaFold prediction reliability), R1-M3 (binding and functional evidence)
- **Assessment against Nature-style criteria** 
  - Originality: The novel fold and the specific mechanistic proposal are potentially original, but the abstract does not provide enough context to assess how distinct this is from prior anti-CRISPR structures.
  - Scientific importance: The work is of interest to the CRISPR community, but the significance relative to existing anti-CRISPR studies is not fully established from the abstract alone.
  - Interdisciplinary readership: The topic bridges structural biology, microbiology, and molecular biology, which could attract a broad audience, but the abstract is written in a fairly specialized manner.
  - Technical soundness: Cannot be assessed from the abstract; no data quality metrics or validation statistics are provided.
  - Readability for nonspecialists: The abstract is reasonably clear but assumes familiarity with CRISPR-Cas terminology and structural biology concepts.
- **Recommendation posture** Supportive if technical concerns are resolved. The claims are plausible and potentially significant, but the current evidence base is insufficient to fully establish the structural and mechanistic conclusions.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Technical soundness
- **Claim pointer** The solution structure of AcrIE5 was determined by NMR spectroscopy, adopting a novel αβ fold comprising three α-helices and two β-strands.
- **Evidence pointer** Abstract; location not provided
- **Concern** The abstract states that the structure was determined, but provides no information on NMR data quality, structural statistics, or validation metrics. Without these, the reliability of the structure cannot be assessed.
- **Why it matters** A claimed novel fold must be supported by high-quality structural data. If the structure is poorly defined or the fold assignment is ambiguous, the central claim of the paper is undermined.
- **Resolution test** Provide NMR restraint statistics, RMSD values, Ramachandran plot analysis, and a clear depiction of the secondary structure assignment in the full manuscript.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Technical soundness
- **Claim pointer** AlphaFold correctly reproduced the experimental structure of AcrIE5 and predicted its binding at a cleft formed by Cas8e, Cas7e, and Cas5e within the P. aeruginosa type I-E Cascade.
- **Evidence pointer** Abstract; location not provided
- **Concern** The claim that AlphaFold "correctly reproduced" the structure and predicted a specific binding interface is presented without any confidence metrics, such as pLDDT scores or predicted aligned error, or experimental validation of the predicted complex.
- **Why it matters** AlphaFold predictions are useful but can be inaccurate, especially for protein-protein interfaces. Without validation, the proposed binding mode remains speculative.
- **Resolution test** Provide AlphaFold confidence scores, a comparison of the predicted and experimental structures, and ideally experimental validation of the binding interface, such as mutagenesis or cross-linking data.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Scientific importance
- **Claim pointer** AcrIE5 may compete with DNA binding to the PAM recognition site of type I-E Cascade, similar to AcrIE3 and AcrIE4, and the conserved mobile loop plays a potential functional role in host-specific anti-CRISPR activity.
- **Evidence pointer** Abstract; location not provided
- **Concern** The mechanistic proposal is based on structural inference and sequence conservation, but no functional data are presented in the abstract. The claim that AcrIE5 competes with DNA binding is explicitly framed as a suggestion, which is appropriate, but the evidence for this is not visible.
- **Why it matters** The functional significance of the structure is a key part of the paper's contribution. Without experimental support, the mechanistic claims remain speculative and the impact of the work is reduced.
- **Resolution test** Provide functional assays, such as DNA binding competition experiments, in vivo inhibition assays, or mutagenesis of the mobile loop to test its role in anti-CRISPR activity.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Readability for nonspecialists
- **Affected element** Abstract text
- **Evidence pointer** Abstract; location not provided
- **Issue** The abstract uses terms such as "Cascade," "PAM recognition site," and "MGEs" without defining them, which may limit accessibility for readers outside the CRISPR field.
- **Required correction** Briefly define these terms or provide a short explanatory phrase when first used.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Scientific importance
- **Affected element** Contextualization
- **Evidence pointer** Abstract; location not provided
- **Issue** The abstract does not clearly state how the proposed mechanism differs from or extends previous studies on AcrIE3 and AcrIE4, beyond a general similarity.
- **Required correction** Add a sentence that explicitly highlights the novel aspects of the proposed mechanism relative to prior work.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Technical soundness
- **Affected element** Sequence conservation claim
- **Evidence pointer** Abstract; location not provided
- **Issue** The claim that the mobile loop is "conserved among homologs encoded by MGEs infecting Pseudomonas species, but truncated in homologs from MGEs of other bacteria" is stated without any supporting data or alignment information.
- **Required correction** Provide a sequence alignment figure or a clear description of the conservation analysis in the full manuscript.

## Risk / unsupported claims
- The claim that AcrIE5 adopts a "novel" fold cannot be verified without a comparison to existing structures and a clear definition of novelty.
- The claim that AlphaFold "correctly reproduced" the experimental structure is unsupported without quantitative comparison data.
- The predicted binding interface and the proposed competition with DNA binding are speculative without experimental validation.
- The functional role of the mobile loop in host-specific activity is inferred from sequence conservation and is not experimentally tested.
- The statement that AcrIE5 "did not bind individual subunits of Cascade with high affinity" is presented without any binding data or experimental details.